• office locations
     
    Bluffton, SC map
    Bluffton, SC Office
    The Plaza at Belfair
    4 Clarks Summit Drive
    Suite 200 | Bluffton, SC 29910-4993
    843.815.2171  Main | 843.815.5991  Fax
     
    Charleston, SC map
    Charleston, SC Office
    100 Calhoun Street
    Suite 400 | Charleston, SC 29401
    843.723.7831  Main | 843.722.3227  Fax
     
    Charlotte, NC map
    Charlotte, NC Office
    Bank of America Plaza
    101 South Tryon Street
    Suite 2610 | Charlotte, NC 28280
    704.347.1170  Main | 704.347.4467  Fax
     
    Columbia, SC map
    Columbia, SC Office
    1221 Main Street
    Suite 1800 | Columbia, SC 29201
    803.799.9800  Main | 803.753.3278  Fax
     
    Greenville, SC map
    Greenville, SC Office
    Poinsett Plaza
    104 South Main Street
    Suite 700 | Greenville, SC 29601
    864.271.4940  Main | 864.271.4015  Fax
     
    Hilton Head Is., SC map
    Hilton Head Island, SC Office
    Shelter Cove Executive Park
    23-B Shelter Cove Lane
    Suite 400 | Hilton Head Island, SC 29928
    843.785.2171  Main | 843.686.5991  Fax
     
    Myrtle Beach, SC map
    Myrtle Beach, SC Office
    Founders Centre
    2411 Oak Street
    Suite 206 | Myrtle Beach, SC 29577
    843.444.1107  Main | 843.444.4729  Fax
     
    Pawleys Island, SC map
    Pawleys Island, SC Office
    11019 Ocean Highway
    Pawleys Island, SC 29585
    843.235.4100  Main | 843.235.4101  Fax
     
  • contact us
      No   Yes  
PROFESSIONALS OTHER CONTENT
     
Instagram

News Room

Print
Share

Consumer Goods Labeling and False Advertising - It's Not Just the FDA AnymoreFebruary 11, 2015

Related Information

Professionals

Locations

Periodically, I run across topics where business, law (especially intellectual property), and technology collide. For example, in August of 2014, the United States Supreme Court issued a ruling in Pom Wonderful, LLC (Pom) v. The Coca-Cola Company (Coke), Docket No. 12-761 that widely impacts the food and beverage industry, and potentially all consumer products.  Pom sued Coke alleging violation of the false advertising portion of the United States trademark laws over Coke's labeling of its product.  Coke released a bottled juice under its Minute Maid brand with the following information on the label: "pomegranate blueberry flavored blend of 5 juices".  However, the product itself contained mostly apple and grape juices, and had only 0.3% pomegranate juice and a small amount of blueberry juices.

Coke's defense argued that it had substantially complied with the FDA juice-labeling regulations and that it is the FDA that determines naming and labeling.  Coke took the position that the FDA's regulations supersede the false advertising claim of Pom. While the trial court and 9th Circuit Court of Appeals agreed with Coke, the U.S. Supreme Court did not and reversed the lower court holding that compliance with the FDA does not allow you to avoid liability under false advertising laws.

This decision will likely lead to additional claims against labeling and packaging since a label that complies with the FDA or FTC is now vulnerable to challenges by private parties.  This is particularly true given the broad definition of "labeling" used by regulatory agencies.  For example, the FDA takes the position that for food products, a label is "all labels and other written, printed or graphic matter upon any article or any of its containers or wrappers or accompanying such article."  (Federal Food, Drug and Cosmetic Act (FFDCA) Section 201(m).)  One appellate court stated that under the FFDCA, "Most, if not all advertising, is labeling. The term 'labeling' is defined in the FFDCA as including all printed matter accompanying any article. Congress did not, and we cannot, exclude from the definition printed matter which constitutes advertising."  United States v. Research Laboratories, Inc., 126 F.2d 42 (9th Cir. 1942).

By stating that the US trademark laws are not preempted by the FDA regulation and by implication, other agency regulations, we should see an increased level of private party false advertising claims both by competitors and class action plaintiffs.  Understanding your risks prior to product launch or rebranding will become even more important.  It is no longer sufficient to consult with your FDA or FTC counsel alone; it is now recommended to consult with an experienced attorney in the fields of trademark, service mark and false advertising.